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Objectives The goal of this study was to use noninvasive conventional and molecular magnetic resonance imaging (MRI) to
detect and characterize abdominal aortic aneurysms (AAAs) in vivo.
Background Collagen is an essential constituent of aneurysms. Noninvasive MRI of collagen may represent an opportunity to
help detect and better characterize AAAs and initiate intervention.
Methods We used an AAA C57BL/6 mouse model in which a combination of angiotensin II infusion and transforming growth
factor– neutralization results in AAA formation with incidence of aortic rupture. High-resolution, multisequence MRI
was performed to characterize the temporal progression of an AAA. To allow molecular MRI of collagen, paramag-
netic/fluorescent micellar nanoparticles functionalized with a collagen-binding protein (CNA-35) were intravenously ad-
ministered. In vivo imaging results were corroborated with immunohistochemistry and confocal fluorescence microscopy.
Results High-resolution, multisequence MRI allowed the visualization of the primary fibrotic response in the aortic wall.
As the aneurysm progressed, the formation of a secondary channel or dissection was detected. Further analysis
revealed a dramatic increase of the aortic diameter. Injection of CNA-35 micelles resulted in a significantly
higher magnetic resonance signal enhancement in the aneurysmal wall compared with nonspecific micelles.
Histological studies revealed the presence of collagen in regions of magnetic resonance signal enhancement,
and confocal microscopy proved the precise co-localization of CNA-35 micelles with type I collagen. In addition,
in a proof-of-concept experiment, we reported the potential of CNA-35 micelles to discriminate between stable
AAA lesions and aneurysms that were likely to rapidly progress or rupture.
Conclusions High-resolution, multisequence MRI allowed longitudinal monitoring of AAA progression while the presence of
collagen was visualized by nanoparticle-enhanced MRI. (J Am Coll Cardiol 2011;58:2522–30) © 2011 by the
American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.09.017Abdominal aortic aneurysms (AAAs) are permanent dila-
tions of the abdominal aorta that exceed the normal diam-
eter by 50% and which present a life-threatening degen-
erative disease. They occur in 5% to 9% of the population
From the *Translational and Molecular Imaging Institute, Mount Sinai School of
Medicine, New York, New York; †Eindhoven University of Technology, Department
of Biomedical Engineering, Laboratory of Chemical Biology, Eindhoven, the
Netherlands; ‡Department of Epidemiology, Atherothrombosis and Imaging, Centro
Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain; §Department
of Vascular Medicine, Amsterdam Medical Center, Amsterdam, the Netherlands;
The Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josee and
Henry R. Kravis Center for Cardiovascular Health, Mount Sinai Medical Center,
New York, New York; ¶Paris Cardiovascular Research Center, Georges PompidouSee page 2531
European Hospital, Paris, France; and the #Department of Medicine, University
of Cambridge, Cambridge, United Kingdom. This study was funded by the
Netherlands Heart Foundation project number 2009SB006, the collaborative
project ATHIM (Atherothrombosis Molecular Imaging), NIH/NHLBI
R01HL070121, and NIH/NIBIB R01EB009638 (Dr. Fayad). All other authors
have reported that they have no relationships relevant to the contents of this paper
to disclose.Manuscript received June 30, 2011; revised manuscript received August 17, 2011,
accepted September 5, 2011.
r
d
a
s
s
A
t
c
s
t
p
s
p
w
t
t
(
e
A
n
M
A
i
d
s
9
b
S
c
c
s
m
l
M
s
o
T
s
p
s
a
q
v
s
M
w
p
m
o
h
c
s
s
2523JACC Vol. 58, No. 24, 2011 Klink et al.
December 6, 2011:2522–30 Conventional and Molecular In Vivo MRI of Abdominal Aneurysmover the age of 65 years and are the tenth leading cause of death
in western countries (1). AAA progression is characterized by
a long period of asymptomatic growth of the abdominal aorta.
Once it reaches 5.5 cm, there is an increased chance of rupture,
with a mortality rate 80%. Surgery and endovascular aortic
epair (EVAR) are currently the only interventions for patients
iagnosed with AAA. These procedures are costly and associ-
ted with high morbidity and mortality rates (2). Generally,
urgery or EVAR is recommended when the AAA reaches a
ize of 55 mm or if the expansion rate is 1 cm/year (2).
lthough currently the best predictor of aneurysm expansion is
he baseline size at diagnosis (3), the prognosis remains
omplex due to the nonlinearity and unpredictability of expan-
ion rates (4). More specific prognostic predictors would offer
he chance to better select intervention strategies for individual
atients.
Different animal models have been developed in the past
everal years to improve the understanding of AAA patho-
hysiology. Recently, Wang et al. (5) introduced a model in
hich a combination of angiotensin II (Ang II) and anti-
ransforming growth factor (TGF)- administered to
C57BL/6 wild-type mice leads to AAA formation and the
occurrence of fatal AAA rupture as high as 80%. Currently,
this is the only animal model that displays such a relevant rate
of AAA rupture, thereby enabling monitoring of the mecha-
nisms at play in this fatal process.
The degradation of the extracellular matrix (ECM) in the
medial wall is key to the formation, progression, and rupture of
AAAs (6). Particularly, the turnover of collagen, an essential
component of the ECM, is known to be responsible for the
remodeling that occurs in the adventitia. Studies indicate that
perturbations in collagen microarchitecture and networks,
probably as a result of collagen degradation and inappropriate
collagen deposition, may alter vessel wall response to mechan-
ical load and lead to vessel wall failure (7). Therefore, imaging
collagen in AAAs might provide valuable information about
the state of aneurysm development and the identification of
AAAs prone to severely progress or rupture.
In the current work, we first explored the use of multi-
sequence, high-field magnetic resonance imaging (MRI) to
characterize the development of AAAs in the aforementioned
model. We then applied recently developed fluorescent/
paramagnetic nanoparticles (8), functionalized with a collagen-
specific protein (CNA-35) (9–13), to identify the presence of
collagen in the aneurysmal wall using molecular MRI. Finally,
in a proof-of-concept experiment, we studied the potential of
CNA-35 micelles to discriminate between stable AAAs and
aneurysms prone to progress and eventually rupture.
Methods
Animal model. All the procedures were approved by the
Mount Sinai School of Medicine Institutional Animal Care
and Use Committee. C57BL/6J male mice (The Jackson
Laboratory, Bar Harbor, Maine) between the ages of 8 and
12 weeks were used. As described in more detail by Wang Aet al. (5), AAAs were induced in
wild-type mice by continuous in-
fusion of Ang II at 1,000 ng/kg/
min for a maximum of 28 days,
along with systemic neutraliza-
tion of TGF-. Briefly, animals
were anesthetized with isoflurane
(4% induction, 1.5% mainte-
nance), and mini-pumps (Alzet,
model 2004 DURECT Corpo-
ration, Cupertino, California)
containing 200 l of Ang II were
implanted subcutaneously. To
achieve systemic neutralization
of TGF-, intraperitoneal injec-
ions of an anti–TGF- antibody
dose: 20 mg/kg) were performed
very other day, which results in
AA formation in the suprare-
al region of the aorta.
ultisequence in vivo MRI of
AA progression. AAAs were
nduced in a group of mice as
escribed above (n  3). MRI
canning was performed using a
.4-T, small-animal, vertical
ore MRI scanner (Bruker Bio-
pec, Bruker, Germany). Each animal was placed in the
enter of a whole-body coil (35-mm inner diameter), under
ontinuous isoflurane anesthesia, which was positioned in the
canner. The animals were connected to a respiratory rate
onitor, and the flow of anesthetic gas was constantly regu-
ated to maintain a breathing rate of 60 breaths/min. Baseline
RI scanning was followed by scans every other day until
acrifice. Each scan session started with a pilot scan with 3
rthogonal slices, followed by high-resolution, black-blood
1-weighted (T1W), T2-weighted (T2W), and proton den-
ity–weighted (PDW) spin echo imaging, of which the exact
arameters are reported in the online version of this paper. The
uprarenal region of the aorta encompassing 22 mm immedi-
tely superior to the right renal artery was imaged. Subse-
uently, a time-of-flight angiography sequence was used to
isualize the blood flow and generate a 3-dimensional recon-
truction of the aorta to allow visualization of vessel dilation.
olecular MRI of collagen. AAAs were induced in
ild-type mice (n  10) according to the aforementioned
rotocol. The presence of an aneurysm was assessed using
agnetic resonance (MR) angiography. CNA-35 micelles
r the mutant Y175K CNA-35 micelles (12) (dose: 50
mol Gd/kg) were injected in the tail vein of the animals
(n  5 for each group). The mice were imaged pre- and 32
ours’ post-injection to allow proper clearance of the mi-
elles from the circulating blood, using a T1W spin echo
equence, with the same parameters as used for the multi-
pectral imaging group (Online Appendix). To ensure that
Abbreviations
and Acronyms
AAA  abdominal aortic
aneurysm
AngII  angiotensin II
CLSM  confocal laser
scanning microscopy
CME  combined Masson
elastin
ECM  extracellular matrix
EVAR  endovascular
aortic repair
MR  magnetic resonance
MRI  magnetic resonance
imaging
NIRF  near-infrared
fluorescence
%NSE  normalized
percentage signal
enhancement
PDW  proton
density–weighted
T1W  T1-weighted
T2W  T2-weighted
TGF  tumor growth factorAA remodeling remained minimal between pre- and
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Conventional and Molecular In Vivo MRI of Abdominal Aneurysm December 6, 2011:2522–30post-imaging sessions, the injections of anti–TGF- antibody
were terminated before the imaging sessions. Animals that
received subcutaneous infusion and intraperitoneal injections
of saline were injected with CNA-35 micelles and used as
controls (n 4). In addition, the half-life of CNA-35 micelles
was investigated by collecting blood samples at different time
points over a period of 24 h. The blood samples were imaged
on the IVIS optical system (Calliper Life Sciences, Inc.,
Hopkinton, Massachusetts), and photon counts were mea-
sured to determine the half-life.
Predictive value of (molecular) MRI for the assessment
of experimental AAA. AAA were induced in C57BL/6
mice (n  8) as described here (10 mg/kg). To study
whether CNA-35 micelles-enhanced molecular MRI can
discriminate between stable AAA lesions and aneurysms
that are prone to severely progress or rupture, animals
underwent MR imaging after intravenous administration of
CNA-35 micelles at days 5 and 15 after the onset of AAA.
These animals were monitored for death or survival,
whereas aneurysm severity (stage I to stage IV) was assessed
by looking at aneurysm morphology as previously described
(14). Mice that suffered from ruptured aneurysms were
classified as stage IV.
Image analysis and statistics. Pre- and post-MR images
were analyzed using OsiriX DICOM Viewer (Geneva,
Switzerland). Each slice was co-registered using the spinal
cord as a landmark. AAAs were identified on the pre-
injection images. A region of interest was drawn around the
aneurysmal wall, and the average signal intensity was mea-
sured (Iwall) over 10 slices throughout the aneurysm. In
ddition, regions of interest were also drawn in the sur-
ounding muscle as well as in the noise, and the average
ignal intensity and SD of the noise were measured, respec-
ively (Imuscle, noise). Signal-to-noise ratios were calculated
for the wall and the muscle (SNRWall  IWallNoise,
SNRMuscle  IMuscleNoise). The contrast-to-noise ratio was
calculated (CNRWM  SNRWallSNRMuscle) and further
normalized to the pre-injection values (CNRNorm 
NRWM postCNRWM pre). Finally, the normalized percentage
ignal enhancement (%NSE) was determined as %NSE 
CNRNorm 1) 100. The data are presented as mean SD.
One-way and 2-way analysis of variance (ANOVA) tests
ere performed to determine statistical significance. A post-
oc Tukey test was performed to compare each of the 3 groups
njected with CNA-35 micelles or mutant CNA-35 micelles.
Bonferroni post-hoc test was performed to compare the
NSE of stages II, III, and IV aneurysms at days 5 and 15 of
AA development. A p value 0.05 was considered statisti-
ally significant. Statistical analysis was performed using
RISM (GraphPad Software, La Jolla, California).
mmunohistochemistry and confocal microscopy. Ani-
als were sacrificed by an isoflurane overdose. Transcardiac
erfusions through the left ventricle were conducted with
aline and paraformaldehyde (4%). The suprarenal aorta was
xcised, collected in optimum cutting temperature medium
OCT), and frozen for further histological examination.ombined Masson elastin (CME) staining was performed
o stain for collagen and elastin fibers. In addition, type I
ollagen and macrophage CD68 staining was performed
sing a primary rabbit anti-mouse type I collagen antibody
nd a primary rat anti-mouse CD68 antibody, respectively
Santa Cruz Biotechnology, Inc., Santa Cruz, California);
he primary antibodies were detected using appropriate
econdary antibodies coupled to an Alexa 647 fluorophore.
or each animal, 10 representative sections were chosen,
xed in 4% paraformaldehyde, and washed twice in
hosphate-buffered saline. The sections were blocked with
% goat serum in phosphate-buffered saline for 20 min at
oom temperature. After blocking, the sections were incu-
ated with the type I collagen primary antibody or CD68
rimary antibody (1:100 dilution) for an hour. After wash-
ng with phosphate-buffered saline, the secondary antibody
as added for 30 min. Finally, the autofluorescence of the
issue was reduced using copper sulfate, and sections were
ounted with DAPI-containing VECTASHIELD
ounting medium (Vector Laboratories Inc, Burlingame,
alifornia) and sealed with coverslips, shielded from light,
nd kept at 4°C until confocal laser scanning microscopy
CLSM) was performed within 48 h. Sections incubated
ith the secondary antibody only were used as negative
ontrols. CLSM imaging was performed with a Leica
p5DM microscope (Leica Microsystems, Wetzlar, Ger-
any). Adjacent sections were stained for type I collagen
nd macrophages to study their respective localization with
egard to the rhodamine-labeled CNA-35 micelles.
esults
haracterization and in vitro binding experiments. The
ynthesis and a schematic of the paramagnetic micelles are
ncluded in the Online Appendix (Online Fig. 1A). The
ize of the micelles before conjugation was 14  1.5 nm,
hereas the CNA-35 and mutant CNA-35–coupled mi-
elles had a mean size of 25  3 nm. Phosphate determi-
ation and protein determination yielded a lipid:protein
atio of approximately 50:1, corresponding to approximately
proteins per micelle. The ionic relaxivity, a measure of
RI contrast–generating potency (15), of bare, CNA-35,
r mutant CNA-35–conjugated micelles was 12 mM–1s–1.
CNA-35 is a natural collagen-binding protein that has
been shown to have affinity for collagen fibers (11). Indeed,
collagen fibers contain a high density of binding sites with
both high and low affinity for the CNA-35 protein, result-
ing in an average constant dissociation value of 500 nm (11).
Our in vitro binding experiment (described in the Online
paper) corroborated these previously published findings
(11). We observed an apparent binding of the CNA-35
micelles to collagen after extensive washing, whereas little
binding occurred for mutant CNA-35 or unconjugated
micelles (Online Fig. 1B). A second in vitro experiment was
performed to further confirm these findings and to investi-
gate the collagen binding of Cy5.5-labeled CNA-35 mi-
2525JACC Vol. 58, No. 24, 2011 Klink et al.
December 6, 2011:2522–30 Conventional and Molecular In Vivo MRI of Abdominal Aneurysmcelles with near-infrared fluorescence (NIRF) imaging using
the IVIS optical imaging system. Similar to the plate reader
studies, we found a clear binding of the CNA-35 micelles to
collagen (Online Fig. 1C). Finally, the blood circulation
half-life of the CNA-35 micelles in male C57BL/6 mice
(n  2) was determined to be 4.3 h.
Multisequence in vivo imaging of AAA progression.
AAAs were induced in male C57BL/6 mice through
continuous infusion of Ang II and administration of anti–
TGF- every other day. The abdominal region of these
mice was imaged using high-resolution, multisequence
MRI to monitor the temporal progression of the AAA at
the anatomical level. T1W, T2W, and PDW MRI, as well
as MRI angiography, were performed. Multisequence MRI
allowed the visualization of the primary fibrotic response in
the aortic wall at day 3. It also revealed luminal stenosis and
medial rupture, with blood infiltrating the adventitial tissue
6 days after AAA induction (Figs. 1A to 1C). At day 8, the
adventitia appeared to be extensively destructed, with the
formation of a double channel clearly visible on different
sequences. The 3-dimensional reconstruction resulting from
the time-of-flight angiography confirmed the aortic dilation
Figure 1 High-Resolution, Multisequence MRI of AAA Progress
(A) T2-weighted (T2W) black-blood imaging of abdominal aortic aneurysm (AAA) pro
is visualized at 3 days after AAA induction in the upper-right corner. At 6 days, the
the formation of a second channel is clearly visible in the bottom-right corner. (B)
Medial rupture is visible here as soon as 3 days after the induction of AAA in the
extravasating in the adventitia is visualized at day 6. At day 8, the formation of th
ing of AAA progression over the course of 8 days. The primary fibrotic response, th
3, 6, and 8 after AAA induction. (D) Three-dimensional magnetic resonance (MR) t
ture and blood infiltration in the adventitia is visible (arrow). (E) Histology with co
radation of the elastic lamina as well as the extreme remodeling of the adventitia
from the 3 sequences (T1W, T2W, and PDW) at each imaging time point and plott
reached 5 days after AAA induction. The days of animals’ death from AAA ruptureand the presence of blood infiltrating the adventitial tissue
(Fig. 1D, arrow). Additional analysis revealed a dramatic
increase in the diameter of the aorta, reaching 50% growth
at day 5 and up to a 150% growth on day 15 (Fig. 1F). To
corroborate the in vivo findings, immunohistological exam-
ination of the aortas was performed at the animals’ death.
The results confirmed the presence of AAAs and allowed
the precise validation of several features of vessel wall
remodeling observed by using in vivo MRI. An extreme
degradation of the ECM was observed due to massive
destruction of adventitial collagen. Only a thin cap re-
mained visible on the outer edge of the aneurysmal wall,
preventing the vessel from rupturing. Intense degradation of
the elastin fibers as well as the complete rupture of the
medial layer of the aorta was clearly identified (Fig. 1E,
arrow). Due to the rupture, blood originating from the
aortic lumen was able to infiltrate the adventitia, thereby
forming a secondary lumen referred to as false channel or
dissection (Fig. 1E). The resulting increase of the aortic
diameter was visibly noted.
In vivo molecular imaging of collagen. Although high-
resolution, multisequence MRI allows the characterization
ver the Course of 8 Days
ion over the course of 8 days. The primary fibrotic response and luminal stenosis
l rupture with blood infiltrating the adventitial tissue is visible (arrow). At day 8,
ighted (T1W) black-blood imaging of AAA progression over the course of 8 days.
right corner. The formation of a false channel with probable disturbed blood flow
channel is clearly visible. (C) Proton density–weighted (PDW) black-blood imag-
ial rupture, and false channel formation were all observed, respectively, at days
-flight angiography of a healthy aorta and AAA. Aortic dilation due to medial rup-
Masson elastin staining confirmed the presence of the medial rupture and deg-
rmation of a false channel. (F) The increase of aortic diameter was averaged
0% increase, which is the minimum size to define the presence of AAA, was
oted and are marked with a cross.ion O
gress
media
T1-we
upper-
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Conventional and Molecular In Vivo MRI of Abdominal Aneurysm December 6, 2011:2522–30of AAA progression on an anatomical level, it does not
provide any information on the underlying molecular biolog-
ical processes. Therefore, we decided to evaluate the presence
of collagen in the same mouse model because it represents a
key constituent of aneurysms. To that end, collagen-specific
CNA-35 micelles were synthesized and injected for
nanoparticle-enhanced MR imaging. Before the injection of
micelles, the presence of aneurysms was evaluated using MR
angiography. T1W MR images were then acquired before and
32 hours after injection of CNA-35 or mutant CNA-35
micelles. In mice injected with CNA-35 micelles, a clear signal
enhancement in the aneurysmal region was observed (Fig. 2A),
whereas a significantly lower signal enhancement was visible
Figure 2 In Vivo MR Molecular Imaging of Collagen
(A) Representative images of animals bearing abdominal aortic aneurysms (AAAs)
micelles caused an important signal enhancement in the aneurysmal wall compar
(%NSE) deriving from the aneurysmal wall was calculated in both groups and is plo
in animals with AAAs caused a significant magnetic resonance (MR) signal enhanc
animals. *p  0.01.
Figure 3 Correlation of In Vivo MRI Findings With Histological
(A) Typical image of an aneurysm after the injection of CNA-35 micelles showing m
tological section stained with combined Masson elastin (CME) showing the presen
tion of the remodeled adventitia with collagen stained in blue. (D) Representative
CNA-35 micelles (red) with collagen I staining (green). (E) Typical image of an ane
resonance signal enhancement in the aneurysmal wall. (F) Corresponding histolog
tion shown in (G). (H) Representative image of fluorescent confocal microscopy o
collagen staining (green). MRI  magnetic resonance imaging.after the injection of mutant CNA-35 micelles. As shown in
Figure 2B, data analysis of the MR images revealed an 80.15
7% increase in %NSE after injection of CNA-35 micelles
ompared with a 30.90% 19% increase after the injection of
utant CNA-35 micelles (n 5; p 0.0048, 1-way ANOVA
est; p  0.05, post-hoc Tukey test). No enhancement was
observed in healthy animals injected with CNA-35 micelles.
Examination of the corresponding histological slices
stained with CME revealed an advanced degree of adven-
titial destruction with the presence of collagen in the areas
of MR signal enhancement (Figs. 3B, 3C, 3F, and 3G).
Importantly, further examination by confocal microscopy
demonstrated the co-localization of the CNA-35 micelles
jected with CNA-35 micelles or mutant CNA-35 micelles. The injection of CNA-35
mutant CNA-35 micelles. The normalized signal enhancement percentage
(B). The data analysis is presented as mean  SD. CNA-35 micelles injected
compared with mutant CNA-35 micelles and CNA-35 micelles injected in healthy
ons and Confocal Fluorescence Microscopy
ic resonance signal enhancement in the aneurysmal wall. (B) Corresponding his-
collagen in the areas of signal enhancement. (C) Represents a 40 magnifica-
of fluorescent confocal microscopy showing the precise co-localization of
after the injection of mutant CNA-35 micelles showing no significant magnetic
ction confirming the presence of collagen stained in blue on the 40 magnifica-
als injected with mutant CNA-35 micelles showing no micelles in the areas ofand in
ed with
tted in
ementSecti
agnet
ce of
image
urysm
ical se
f anim
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December 6, 2011:2522–30 Conventional and Molecular In Vivo MRI of Abdominal Aneurysm(red) with collagen-I (green) in the adventitia (Fig. 3D). In
animals injected with mutant CNA-35 micelles, the fluo-
rescent signal originating from the micelles was found to be
nearly nonexistent in the regions that stained positively for
type I collagen (Fig. 3H). In addition, CLSM images of
macrophage stained with a CD68 antibody revealed no
association between macrophages and CNA-35 or mutant
CNA-35 micelles (data not shown). It is noteworthy that
mutant CNA-35 micelles were not associated with any specific
biological structures. In addition, the collagen MR signal
enhancement pattern observed in different animals allowed
differentiation between collagen-rich and collagen-poor lesions
as observed on corresponding CME stains (Fig. 4).
Ex vivo fluorescence imaging. To corroborate the CNA-35
micelles-enhanced in vivo MRI results and to investigate their
spatial distribution in the aorta, Cy5.5-labeled micelles were
injected in mice after AAA development as well as in healthy
animals. NIRF imaging, a so-called hotspot imaging technique
(16), allows the visualization of the Cy5.5-labeled micelles with
high sensitivity in intact aortas (17,18). Mice were sacrificed 32
hours post-injection, and the excised aortas were imaged with
NIRF imaging. Cy5.5-labeled CNA-35 micelles were clearly
observed in the AAA region (Online Fig. 2). In comparison,
healthy animals and noninjected AAA animals marginally
displayed fluorescent signals, further supporting the specific
binding of CNA-35 micelles in the aneurysmal region.
Figure 4 Spatial Correlation Between the Pattern of MR Signal
(A) Representative image of a collagen-rich aneurysmal lesion after the injection o
of magnetic resonance (MR) signal enhancement (arrows) by combined Masson e
aneurysmal lesion after the injection of CNA-35 micelles. A thin layer of collagen w
ment (arrows) as shown in D.Predictive value of (molecular) MRI for the assessment
of experimental AAA. As described here, the injection of
CNA-35 micelles allowed the discrimination between
collagen-poor and collagen-rich lesions (Fig. 4). It has been
shown in the literature that low levels of collagen are
associated with AAA progression and ultimately rupture
(7). Hence, we hypothesized that CNA-35 micelles have
the potential to discriminate between stable AAA lesions
and aneurysms that are prone to progress or rupture. We
imaged CNA-35–injected animals at days 5 and 15 of AAA
development and subsequently monitored them for survival.
On death or sacrifice, the aneurysm severity was evaluated
by looking at the aneurysm morphology as previously
described (14). Administration of anti–TGF- in Ang
II–infused mice led to mortality from aneurysm rupture
(stage IV) in 3 mice, whereas the remaining 5 animals
survived bearing stage II and III AAAs. All the main
features of human aneurysms ranging from the fibrotic
response around the vessel wall to signs of medial dissection
and formation of a secondary channel were observed.
As shown in Figure 5, animals that were morphologically
classified with stage II aneurysms displayed marked en-
hancement after CNA-35 administration at days 5 and 15
of aneurysmal development, suggesting a collagen-rich re-
sponse of the aortic wall. These lesions were stable, as no
aortic dissection and medial rupture were observed, and the
ncement and the Collagen Content Observed by Using Histology
-35 micelles. The high collagen content was confirmed to be present in the area
histological staining as shown in C. (B) Representative image of a collagen-poor
ntified by combined Masson elastin staining in the region of MR signal enhance-Enha
f CNA
lastin
as ide
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administration. In contrast, all the mice retrospectively
classified with stage III and IV aneurysms (n  5) exhibited
a dissection of the media at day 5 (Fig. 5A, arrow) and
showed a marked decrease of approximately 30% in %NSE
in both groups relative to stage II AAAs (48.50  4.950 vs.
72.01  10.47 [p  0.05] and 46.68  7.652 vs. 72.01 
10.47 [p  0.05], respectively) (Fig. 5B). Imaging at day 15
showed a critical progression of AAA development with an
extensive remodeling of the vessel wall and presence of a
secondary channel. Ruptured stage IV aneurysms showed
little signal enhancement after CNA-35 injection, suggest-
ing a lower collagen content as opposed to nonruptured
stage II and III aneurysms (52.13  8.408% vs. 120.7 
19.49% [p  0.001] and 52.13  8.408% vs. 87.51 
3.521% [p  0.05], respectively) (Fig. 5B). Consistent with this
hypothesis, histological examination on the death of the animals at
days 19, 22, and 23 revealed substantial collagen degradation in
fatal aneurysms compared with viable stage II and III AAAs. A
2-way ANOVA test revealed that both factors (stage of aneurysm
Figure 5
CNA-35–Enhanced MR Imaging of
AAAs of Increasing Severity at Early and
Late Stage of Development and Complications
(A) Typical images of stage II, III, and IV abdominal aortic aneurysms (AAAs)
obtained after CNA-35 injection at day 5 and day 15 of AAA development. Cor-
responding histological sections stained with combined Masson elastin (CME)
are shown in the third column. (B) Quantification of aneurysm severity (increas-
ing from stage I to IV) and normalized signal enhancement percentage (%NSE)
relative to CNA-35 injection in a group of mice (n  8).and time) significantly alter %NSE (p 0.0027 and p 0.0024,respectively) and that there is a significant interaction between the
2 factors (p  0.0407). These findings show a potential for
CNA-35 micelles to discriminate between stable AAA lesions
with important collagen content and aneurysms that are likely to
rapidly progress and eventually rupture.
Discussion
In the current study, we demonstrated the ability of high-
resolution conventional and molecular MRI to detect key
anatomical features of aneurysmal progression and to identify
the presence of collagen in the aneurysmal wall in a new AAA
mouse model. Conventional multisequence black-blood MRI
permitted the visualization of the different stages of AAA
progression. Over the course of aneurysm development, we
reported the accurate identification of the primary fibrotic
response in the vessel wall with consequent luminal stenosis.
As the aneurysm progressed, we visualized the medial rupture
with blood infiltrating the remodeled adventitia, which re-
sulted in the formation of a double channel. The ensuing
increase in aortic diameter was clearly noted and quantified.
Histological examination on the death of the animals matched
the MR observations and confirmed the presence of the
aforementioned landmarks of aneurysmal progression.
Molecular MRI, via intravenous administration of collagen-
targeted CNA-35 micelles, provided valuable information
about the presence of collagen in the aneurysmal wall. The
injection of CNA-35 micelles resulted in a significantly higher
MR signal enhancement than the injection of mutant
CNA-35 micelles. Histological staining for collagen in corre-
sponding sections confirmed the presence of collagen in the
areas of MR signal enhancement. Additional examination with
fluorescent confocal microscopy demonstrated the precise co-
localization of CNA-35 micelles with collagen stained in the
remodeled adventitia. Importantly, in a proof-of-concept ex-
periment, CNA-35 micelle-enhanced MRI allowed the dif-
ferentiation between stable AAA lesions and aneurysms that
are likely to rapidly progress and rupture.
Imaging technologies in general, and ultrasound imaging in
particular, are currently used to obtain information related to
AAA in humans (19,20). An angiography is routinely per-
formed to obtain preoperative anatomical information on the
aneurysm and its relationship to surrounding structures (21).
However, disadvantages include the use of contrast and expo-
sure to radiation. As for ultrasound imaging, it is widely used
to monitor AAA progression, but it provides little contrast and
suffers from a poor signal-to-noise ratio, which limits the
ability to obtain a detailed evaluation of the remodeled adven-
titia, particularly in preclinical studies involving small-animal
models. Although some recent reports have shown the ability of
ultrasound Doppler to identify medial rupture and differentiate
between the lumen and the false channel in mice (5), the
resolution of ultrasound remains subpar compared with MRI.
Recently, MRI has been used successfully by Turner et al.
(22) to assess the development of an Ang II–induced
aneurysm model in hypercholesterolemic mice. The inves-
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December 6, 2011:2522–30 Conventional and Molecular In Vivo MRI of Abdominal Aneurysmtigators revealed that MR measurements of the AAA area
performed on a bright-blood sequence were precisely cor-
related with the AAA area measured by using histology. In
the current study, the aortic diameter measured with 3
different MR methods (T1W, T2W, and PDW) was
evaluated at each imaging time point. The results showed a
fast increase of the aortic diameter reaching 50% (the
minimum value to define an aneurysm) 5 days after the
initiation of the experiment on average. In addition to
providing aortic diameter measurements, multisequence
black-blood imaging offered superior contrast compared
with bright-blood sequences for the examination of vessel
wall remodeling during AAA formation and progression.
Furthermore, it allowed the accurate identification of the
medial rupture and formation of a double channel, similar to
bright-blood imaging. Particularly on the T1W sequence,
the medial rupture was clearly identifiable as soon as 3 days
after AAA induction compared with the T2W and PDW
sequences, which did not allow such evident visualization
until 6 days after aneurysm initiation (Fig. 1B). In addition,
multisequence black-blood imaging also offered adequate
resolution to image the medial-adventitial interface. Indeed,
despite various degrees of aortic stenosis caused by different
degrees of collagen degradation and thrombus formation,
the lumen always remained easily distinguishable from the
remodeled adventitia, even on blood extravasation in the
adventitial space. Multisequence black-blood MR imaging
offers the benefit of increased accuracy in characterizing the
anatomical features of AAA temporal progression.
One of the biological processes underlying AAA formation
and progression is the degradation of the ECM, particularly
collagen. Members of the matrix metalloproteinase and cys-
teine protease families can degrade the highly protease-
resistant structures of type I and type III collagen (23–25).
After the destabilization of the collagen structure, other less
specific proteases can further degrade collagen. This increased
collagen degradation in combination with inadequate collagen
deposition has been associated with the progression and
ultimately rupture of AAAs. Therefore, imaging collagen
might offer additional insights about the state of aneurysm
progression. CNA-35 consists of 2 N domains (N1 and N2)
from a collagen adhesion protein originating from Staphylococ-
cus aureus and was used as a targeting ligand. Its specificity for
collagen was previously demonstrated in vitro and in vivo
(9,10,12,13). In its open conformation, the CNA-35 protein
can fold and lock around the collagen fiber (11). This binding
rocess implies that CNA-35 micelles would also adhere to
ndividual triple helical fibers of collagen, which are hardly
resent in healthy tissue, in addition to binding to mature
ollagen fibers. Degraded collagen and newly formed collagen
bers, highly present in advanced stages of AAA, are associ-
ted with high portions of free triple helices. Therefore, the
right signal enhancement observed in the aneurysmal wall of
nimals injected with CNA-35 micelles might derive from a
ombination of the micelles’ increased affinity to mature
ollagen fibers as well as to unstructured collagen present in nAAs (7). When CNA-35 micelles were injected in animals
n healthy animals, no MR signal enhancement was observed
Fig. 2B). Given the size of these particles (25 nm), their
nability to penetrate healthy tissue is likely to be the limiting
actor to collagen binding.
It is apparent that the degree of adventitial collagen degra-
ation relates to the stage of aneurysmal severity. In fact, it has
een shown previously that increased collagen degradation is
ssociated with AAA progression and ultimately rupture (7).
hus, one could argue that increased level of collagen in the
ortic wall stabilizes the aneurysm. We therefore hypothesized
hat CNA-35 micelles would allow the distinction between
table collagen-rich AAA lesions and collagen-poor lesions
hat are more likely to progress and rupture. To that end, we
esigned a proof-of-concept experiment in which the normal-
zed signal enhancement relative to CNA-35 injection was
alculated at early and late stage of AAA development and
orrelated with the aneurysm severity determined by their
orphology (stage I to IV). Our findings revealed the ability of
NA-35 micelles to identify stable aneurysms, as the collagen-
ich response of the aortic wall of noncomplicated lesions was
ecognizable with a high NSE percentage value (Fig. 5). In
ddition, a decrease of CNA-35 uptake at early stage of
neurysmal development (day 5) in stage III and IV aneurysms
as associated with a rupture of the medial layer of the aorta
nd subsequent critical AAA progression. Interestingly, the
edial rupture seemed to occur in the areas of lowest CNA-35
ptake (Fig. 5, arrow). Importantly, lesions with the lowest
NSE value that did not increase at follow-up were identified
s fatal stage IV aneurysms and presented critical collagen
egradation compared with viable stage III aneurysms.
Although collagen is likely not the only biological com-
onent at play in AAA progression and rupture, its precise
onitoring may benefit diagnosis and staging of the aneu-
ysm. Our results show that CNA-35 micelle-enhanced
RI represents an extremely interesting concept for the
etection of collagen in the aneurysmal wall and has
otential for predicting the course of AAA development.
owever, because of the low number of animals per group
n that experiment, more extensive studies are necessary to
onfirm the predictive value of CNA-35 micelle-enhanced
RI in assessing AAA progression/rupture.
The current clinical guidelines (26) for the management of
neurysms are mainly based on the size of aneurysms and
ecommend repeated anatomical imaging every 3 to 6 months
or aneurysms 4 cm. Endovascular repair or surgery is
ecommended for AAAs that are 5.5 cm, symptomatic, or
ast growing. Intervention is not indicated when these criteria
re not met as the chance of rupture is 2.1% (25). The high
ate of mortality associated with reparative surgery would
xpose patients to unnecessary risks. Noninvasive imaging
pproaches, such as high-resolution multisequence black-
lood MRI and collagen-targeted MRI described in this study,
ould ultimately improve the identification of patients at risk
nd facilitate the clinical management of AAAs (27). It is
oteworthy that other biological targets involved in AAA
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improve the characterization of the aneurysmal wall. Nahren-
dorf et al. (28) developed a macrophage-targeted nanoparticle
for positron emission tomography–computed tomography de-
tection of inflammation in aortic aneurysms. Recently, a pilot
study used ultrasmall superparamagnetic iron oxide nanopar-
ticles uptaken to predict aneurysm growth in humans (29). In
ddition, such anatomical and biological information obtained
ay replace the preoperative need of a computed tomography
ngiography.
onclusions
e revealed that high-resolution, multisequence MRI al-
owed the visualization of critical features of vessel remod-
ling inherent to AAA formation and progression, whereas
ollagen-targeted nanoparticle-enhanced MRI permitted
he noninvasive detection of collagen, an essential compo-
ent in aneurysm pathology.
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